These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28696562)

  • 1. Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes.
    Zou Y; Li X; Wang C; Wang J; Wang F; Ma L; You W; Li C
    Intern Med J; 2017 Oct; 47(10):1147-1153. PubMed ID: 28696562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors.
    Agarwal AK; Singh M; Arya V; Garg U; Singh VP; Jain V
    J Assoc Physicians India; 2012 Jul; 60():28-32. PubMed ID: 23405538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes.
    Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S
    Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
    Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
    Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Artery Disease and Risk of Fibrosis Deterioration in Nonalcoholic Fatty Liver Disease: A Prospective Investigation.
    Zhu W; Deng CJ; Xuan LP; Dai HJ; Zhao ZY; Wang TG; Li M; Lu JL; Xu Y; Chen YH; Wang WQ; Bi YF; Xu M
    Biomed Environ Sci; 2020 Apr; 33(4):217-226. PubMed ID: 32438959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
    Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalent peripheral arterial disease and inflammatory burden.
    Cauley JA; Kassem AM; Lane NE; Thorson S;
    BMC Geriatr; 2016 Dec; 16(1):213. PubMed ID: 27938334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.
    Ni L; Yu D; Wu T; Jin F
    Medicine (Baltimore); 2021 Feb; 100(6):e24743. PubMed ID: 33578624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.
    Britton KA; Mukamal KJ; Ix JH; Siscovick DS; Newman AB; de Boer IH; Thacker EL; Biggs ML; Gaziano JM; Djoussé L
    Vasc Med; 2012 Apr; 17(2):85-93. PubMed ID: 22402937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
    Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population.
    Sun W; Zhang D; Sun J; Xu B; Sun K; Wang T; Ren C; Li J; Chen Y; Xu M; Bi Y; Xu Q; Wang W; Gu Y; Ning G
    QJM; 2015 Aug; 108(8):617-24. PubMed ID: 25614616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    Gummesson A; Strömberg U; Schmidt C; Kullberg J; Angerås O; Lindgren S; Hjelmgren O; Torén K; Rosengren A; Fagerberg B; Brandberg J; Bergström G
    PLoS One; 2018; 13(8):e0202666. PubMed ID: 30133541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ankle systolic pressure index in non-diabetic non-alcoholic fatty liver disease: A case-control study.
    Taharboucht S; Guermaz R; Brouri M; Bengherbia L; Chibane A
    J Med Vasc; 2023; 48(5-6):154-162. PubMed ID: 38035921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.